Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InnoPep is a biotechnology company based in San Diego, California, that specializes in high-quality custom peptide synthesis and related services for the life sciences industry. The company provides a comprehensive suite of products, including an extensive catalog of research peptides and specialized reagents for drug discovery. InnoPep's technical capabilities include complex peptide modifications such as phosphorylation, methylation, biotinylation, and the incorporation of non-natural amino acids. They support pharmaceutical, biotechnology, and academic researchers with services ranging from small-scale synthesis to large-scale production for preclinical development. Additionally, InnoPep offers peptide library construction and consultation for therapeutic peptide design, positioning themselves as a key partner in the peptide-based drug development space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InnoPep.